The biopharma world – and markets – spent Thursday evening reacting as the FDA gave the green light to only its third-ever drug for ALS, Amylyx’s AMX0035.
https://www.pharmalive.com/wp-content/uploads/2022/09/BioSpaceAmylyxCEOs.jpg350625BioSpacehttps://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.pngBioSpace2022-09-30 11:45:552022-09-30 11:45:55FDA approves third-ever drug for ALS - Amylyx's AMX0035
